Share on StockTwits

GenVec (NASDAQ:GNVC) major shareholder Ecor1 Capital, Llc acquired 24,140 shares of GenVec stock in a transaction dated Tuesday, May 27th. The shares were purchased at an average price of $2.24 per share, with a total value of $54,073.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

GenVec (NASDAQ:GNVC) traded up 6.19% on Tuesday, hitting $2.40. The stock had a trading volume of 28,088 shares. GenVec has a 52 week low of $0.25 and a 52 week high of $4.25. The stock has a 50-day moving average of $2.42 and a 200-day moving average of $2.65. The company’s market cap is $41.4 million.

GenVec (NASDAQ:GNVC) last issued its quarterly earnings data on Monday, May 12th. The company reported ($0.07) EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.04 by $0.11. The company had revenue of $2.10 million for the quarter, compared to the consensus estimate of $2.00 million. On average, analysts predict that GenVec will post $-0.40 earnings per share for the current fiscal year.

GenVec, Inc (NASDAQ:GNVC) is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.